[Pharmacology of neurodegenerative diseases: perspectives on cellular and gene therapies].

Treatment of degenerative diseases includes neuroprotective strategies. Among these, the importance of the different neurotrophic factors has been demonstrated but the remaining difficulty is the way of administration. It is important to find new strategies in cell and gene domains. Cell ex vivo therapy and gene in vivo therapy are under development but must be confirmed by clinical trials.